Skip to content
KStart free
AI InfrastructureDefenseQuantumAll studies →

A Study to Learn How Nusinersen (Spinraza) Affects Participants With Spinal Muscular Atrophy (SMA) Who Took it Before or During Pregnancy And About The Health of Their Babies

← catalyst calendar

NCT05789758 · readout in 2,265 d

Sponsored by Biogen (industry) · BIIB — their whole pipeline →.

Phase
Status
Recruiting
Study type
Observational
Enrollment
20estimated
Sites
14
Countries
United Kingdom, United States

Every value on this page is a field the sponsor filed with ClinicalTrials.gov, reproduced. Dates are their own estimates, revised as a study runs, unless the registry marks them actual. sources →

Source: ClinicalTrials.gov, retrieved 2026-08-19

Dates

each axis at the precision it was filed, with the registry's own basis
DateFiledBasisWhat it is
Start2023-12-15actualWhen the study began enrolling
Primary completion2032-10-31estimatedThe date the last participant is measured for the primary outcome — the readout window
Study completion2033-10-31estimatedThe whole study's end, after follow-up
First posted2023-03-29actualWhen this record first appeared on the registry
Results postedWhen the sponsor posted results to the registry
Record updated2026-03-09actualThe sponsor's own last edit to this record — every projection above is as current as this date

What it studies

Condition

  • Muscular Atrophy, Spinal

Intervention

  • Other: No Intervention

Primary outcomes

what the primary-completion date above is the date OF
Number of Pregnancy Terminations
measured Up to 10 years
Number of Spontaneous Abortions
measured Up to 10 years
Number of Fetal Deaths
measured Up to 10 years
Number of Live Births
measured Up to 10 years
Number of Neonatal, Perinatal, and Infant Deaths
measured Up to 10 years
Number of Major Congenital Malformations (MCMs)
measured Up to 10 years
Number of Infants Small for Gestational Age Birth
measured Up to 10 years
Number of Ectopic and Molar Pregnancies
measured Up to 10 years
Number of Maternal Deaths
measured Up to 10 years
Number of Infants With Abnormal Postnatal Growth and Development and Neurobehavioral Impairment
measured Up to 10 years

Permalink · BIIB's whole pipeline · Catalyst calendar · Every registered study · What changed